Pulmonx Corp (LUNG): Market Cap to Revenue

Symbol and logo of brand Pulmonx Corp. (LUNG)

The recruitment of qualified biomedical specialists and surgeons to combat emphysema has served as a growth catalyst for Pulmonx Corporation (LUNG), as reflected in the market cap-to-revenue ratio on this GURU.Markets chart. The 1.40 mark indicates the level achieved through the implementation of invasive respiratory systems. Stable management has solidified this success by effectively scaling sales while maintaining strict cost controls.

LUNG Pulmonx Corp. P/S Multiple (07/04/2022 - 11/15/2026)

Analytical breakdowns for Pulmonx Corp (LUNG)

- share price and consensus valuation forecast:
General company analysis:LUNG Pulmonx Corporation
Core merchandise of Pulmonx

The P/S multiple determines the market value of one dollar of revenue, allowing for an assessment of the premium paid for a business regardless of current earnings. By analyzing current P/S dynamics, an investor can see the ratio of market capitalization to sales volume. This metric is sensitive to revenue growth expectations, which is critical for companies in the expansion stage. For Pulmonx Corporation (LUNG), this reflects the demand for emphysema treatment systems, which offsets the impact of macroeconomic downturns.

Competitors of Pulmonx Corporation

DXCM (DexCom Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple PEN (penumbrainc.com)|NOVT - Market Cap to Revenue|Haemonetics - P/S Multiple|Price to Sales Inspire Medical Systems|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Medical) - P/S Multiple|InMode Corp (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics, Inc. SRDX|P/S Multiple SENS (senseonics.com)|P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|Outset Medical Corp (OM) - Price-to-Revenue Ratio|SmartVest - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR Inc) - P/S Multiple|Price to Sales AVITA Medical Inc. RCEL|Price-to-Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Price-to-Revenue Multiple|EDAP TMS SA - Market Cap to Revenue|P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio TELA|CytoSorbents Corporation (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus)|Price-to-Revenue Ratio zynex.com|Market Cap to Revenue electroCore, Inc. (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|SeaStar Medical - Market Cap to Revenue|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|beyondair.net - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack|P/S Multiple NanoVibronix Inc.|Price-to-Revenue Ratio Venus Concept (VERO)|Market Cap to Revenue Nuwellis, Inc. NUWE|P/S Multiple AEMD (Aethlon Medical, Inc.)|ASXC: Market Cap to Revenue Ratio|Avinger Inc. - P/S Multiple|Price-to-Revenue Coefficient BioSig Technologies, Inc BSGM|CUTR: P/S Multiple|Know Labs, Inc. (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical Inc|Market Cap to Revenue Nevro Corp (NVRO)|Market Cap to Revenue RSLS (ReShape Lifesciences, Inc.)|P/S Multiple Silk Road Medical Inc. (SILK)